Propofol is an intravenous anesthetic agent widely used to introduce and maintain anesthesia during surgical procedures, and it has often been used in recent years as a sedative in patients with acute lung injury (ALI). A common cause of ALI is sepsis, and apoptosis in vascular endothelium and alveolar epithelial cells (AECs) during sepsis plays an important role in the pathologic formation of ALI. Propofol has drawn greater attention due to its anti-inflammatory effect and anti-apoptosis capability. It was already found that propofol inhibited MCP-1 mRNA expression and secretion, as well as the phosphorylation of 
Introduction
Propofol is an intravenous anesthetic agent widely used to introduce and maintain anesthesia during surgical proce- Propofol has often been used in recent years as a sedative in patients with acute lung injury (ALI), which is a common and critical pulmonary complication. ALI is an inflammatory disorder characterized by an excessive infiltration of neutrophils, the release of inflammatory mediators, and destruction of the alveolar-capillary membrane with severe consequences for pulmonary gas exchange (4) (5) (6) . A common cause of ALI is sepsis, and apoptosis in vascular endothelium and AECs during sepsis plays an important role in the pathologic formation of ALI. In mouse septic lungs, the surface expression of death receptors is up-regulated and the adaptor molecule Fas-associated death domain is highly expressed, and also the apoptotic effectors such as caspase-8 and caspase-3 are expressed and activated. Thus, the death receptor apoptotic pathway is critical for the development of ALI during sepsis (7) . In addition, alveolar epithelial injury in humans with ALI is in part associated with local up-regulation of the Fas/FasL system and activation of the apoptotic cascade in the epithelial cells that line the alveolar air spaces (8) .
Several studies have reported that propofol has antioxidating potential to attenuate hydrogen peroxide-induced PC12 cell death through p38 MAPK and protects against oxidative stress in human umbilical vein endothelial cells and human hepatic cells (9) (10) (11) (12) . However, there is only limited information about the effect of propofol on apoptosis in AECs.
The present study investigated the effect and mechanism of propofol on apoptosis induced by hydrogen peroxide (H 2 O 2 ) in AECs. 
Materials and Methods

Cell culture
Cell proliferation assay
AECs were treated with 0.1 μM H 2 O 2 (Wako Pure Chemical Industries, Ltd., Japan) for 24h following pretreatment with 25 μM propofol (2, 6-diisopropylphenol, Tokyo
Chemical Industry Co., Ltd., Japan) for 1h in a medium with 0.5% FBS. The cell proliferation assay was performed using the Cell Proliferation Assay System, TetraColor ONE (Seikagaku Biobusiness Corporation, Japan) and Microplate
Reader MTP-450 (Corona Electric Co., Ltd., Japan). Reagents (GE Healthcare UK Ltd., Buckinghamshire, UK).
Flow cytometry analysis
Statistical analysis
Data were expressed as the mean ± SD. Differences among multiple groups were expressed by one-way ANOVA, followed by the Bonferroni post hoc test. P values of < 0.05 were considered as statistically significant. 
Results
Effect of propofol on cell proliferation in H
Discussion
Propofol, a widely used anesthetic and sedative, has recently drawn greater attention due to its anti-apoptosis capability. Several studies have reported that propofol limits myocardial ischemia/reperfusion injury with an associated reduction in apoptotic cell deaths in rats (13) , and it attenuates intestinal ischemia/reperfusion induced intestinal epithelial apoptosis which might be attributable to its antioxidant property modulating the ceramide pathway (14) . Moreover, propofol protects hepatic L02 cells from These results suggest that the application of propofol has potential to reduce apoptosis through the JNK pathway and Bim down-regulation.
